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Abstract 29 
A current morphological population balance (MPB) modelling methodology, which integrates crystal 30 
morphology, facet growth kinetics with multi-dimensional population balance, is overviewed and 31 
demonstrated, hence providing an attractive approach for modelling crystallisation processes. MPB 32 
modelling is applied to simulate the batch crystallisation of the alpha-form of para-aminobenzoic acid 33 
from ethanolic solutions as a function of the crystallisation environment including cooling rate, 34 
seeding temperature and seed conditions (loading, size and shape). The evolution of crystal shape/size 35 
and their distributions revealed that higher loading led to smaller and less needle-like crystals with 36 
similar yields, hence potentially being an important parameter for process control. Examination of 37 
the development of the fracture surface for broken seeds, mimicking the seed conditions after milling 38 
in practice in the simulated processes, demonstrated that these faces grew fast and then rapidly 39 
disappeared from the external crystal morphology. Restriction and challenges inherent in the current 40 
model are also highlighted. 41 
 42 
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1. Introduction 46 
Recent reviews (Bell, 2017, Maier, 2017) have highlighted that the development of new technologies 47 
has the potential to deliver a step-change in the way we make medicines through the adoption of state-48 
of-the-art simulation-based tools. Through this, PRUH µQHDU SDWLHQW¶ PHGLFLQHV (combination 49 
medicines, wider range of dosage forms, stratified formulation) can be delivered through the much 50 
greater agility provided by digital design and automation. Digital design potentially provides the route 51 
to the preparation of the solution re-crystallised pharmaceuticals which have e.g. low structural 52 
variability, high purity and narrow size/shape distribution with concomitantly enhanced product 53 
properties. Such materials could have significant patient benefits such as narrow therapeutic profiles, 54 
higher stability and longer shelf life, greater content uniformity, etc. and as such represent a critical 55 
objective for the delivery of medicines with pre-defined properties for industry and society. Active 56 
pharmaceutical ingredient (API) and excipients used in their formulation often have well-defined 57 
crystal morphologies and hence surface chemistry, and thus their physical properties can be defined 58 
and manipulated through modelling, optimisation and control of crystallisation processes. Such 59 
surface properties can provide the key parameters for delivering both drug product quality (such as 60 
high purity and lack of variability) and performance (such as bioavailability and stability), and also 61 
ensuring the same particles encompassed within the API are present in the formulated drug product 62 
and are also transferred from R&D into manufacturing stage. 63 
Most drugs are still manufactured in the traditional way, i.e. through processes designed to deliver 64 
tasks such as crystallisation for enabling product purity, form and yield. However, each of these 65 
discrete steps is not necessarily considering and/or directly linking with their resultant effect of the 66 
resultant crystal properties on the downstream processes. Therefore, a crystallisation process 67 
generally produces crystals with dispersion of size/shape. However, for the growing area of targeted 68 
medicines, such variations create challenges as they have mindful of their potentials to affect the drug 69 
crystal¶s dissolution and hence its efficacy, i.e. crystals with different sizes/shapes create variability 70 
in the in-vitro dissolution. Currently, to achieve the required size/shape and their distributions for 71 
drug formulation, crystal particles are milled to effect the size reduction needed. However, such 72 
intensive mechanical processing FDQLPSDFWRQWKHFU\VWDO¶V surface properties through the creation 73 
of new high surface energy, fracture surfaces and lattice defects such as dislocations, as well as 74 
significantly enhancing surface roughness and hence area. In extreme cases, milling can cause 75 
polymorphic form transformation. Similarly, blending/granulation for mixing with binder/excipients 76 
to produce granules may need to be broken into smaller size for compaction/tableting processes. In 77 
principle, crystals and excipients could be produced with a much tighter specification such that they 78 
could be directly compressed and tabletted into the final product without the need for milling and 79 
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granulation processes, and also avoiding variability due to changes in, and/or damage to, crystal 80 
surface properties. In pharmaceutical product development, crystallisation processes are widely used 81 
but many ingredients exhibit needle-like, plate-like or rod-like crystal morphologies, which can 82 
directly affect their downstream particle processing properties such as filterability, flowability, 83 
tabletability. Therefore, digital design of crystallisation processes based on first-principles physical 84 
chemical models can become an important bottleneck to breakthrough.  85 
Traditional population balance (PB) models use a length (or radius of a volume equivalent sphere) 86 
for one-dimensional characteristic size or length and width for two-dimensional characteristic sizes 87 
with a shape factor for calculating crystal volume. Assuming the crystal morphology does not change 88 
during crystallisation processes, the evolution of crystal shape/size could be represented (e.g., 89 
(Lovette et al., 2008, Zhang and Doherty, 2004, Kuvadia and Doherty, 2013)). Morphological PB 90 
(MPB) (e.g. (Ma et al., 2008)) was developed to remove the assumption that crystal morphology is 91 
invariant during crystallisation, through directly integrating both base crystal morphology and face-92 
specific growth kinetics with the PB model, hence capturing the change of crystal shape/size and 93 
through this their face {hkl}-specific properties. A more detailed review of previous work is given in 94 
Supplementary materials (S1). 95 
In this paper, the MPB method is overviewed and demonstrated through a numerical study of a 96 
pharmaceutical compound, D-pABA, crystallised from ethanolic solution. In this, the face-specific 97 
growth mechanisms and rate equations were obtained by fitting the experimental data as obtained 98 
from the literature (Toroz et al., 2015). The performance of crystallisation processes is examined 99 
using MPB modelling to predict the evolution of crystal shape/size distributions in a seeded batch 100 
cooling crystalliser under different cooling rate, seeding and seed conditions including assessing the 101 
impact of broken seeds on the properties of the final products.  102 
  103 
2. Morphological Population Balance for Crystallisation Process Design 104 
2.1 MPB Modelling Framework 105 
The framework for prediction of the distributions of crystals size and shape for crystallisation 106 
processes using MPB modelling is schematically shown in Figure 1. For the known crystal shape and 107 
size, the centre of the crystal and the corresponding normal distances from individual faces, which 108 
can be defined by the Miller Index {hkl} (a notion system in crystallography for crystal planes/faces) 109 
such as {h1k1l1}, {h2k2l2} and {h3k3l3} in Figure 1, to the centre can be determined with individual 110 
variables such as x1, x2 and x3 in Figure 1. During crystallisation processes, these variables are under 111 
continuous evolution as the processes are controlled by various crystallisation mechanisms including 112 
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nucleation, growth, agglomeration, breakage and crystallisation environment. Therefore these 113 
variables can be treated as the independent variables for the formulation of MPB equation. As shown 114 
in Figure 1, nucleation, face-specific growth kinetics, face-based agglomeration and breakage kernels 115 
are the key input parameters for MPB modelling, which can be determined through various modelling 116 
and experimental studies. The solution of the MPB equation will generate the evolution of these 117 
independent variables, i.e. normal distances, of all crystals, hence their distributions at each 118 
crystallisation time. Based on the known crystal morphology, each combination of normal distances 119 
(x1, x2, x3) represents a crystal shape with the distribution providing the number of crystals having 120 
this shape. Therefore, after the crystal size/shape analysis, a crystal shape distribution can be formed 121 
and examined to see whether the distribution meets the requirements for precision particles. If not 122 
(Figure 1), the MPB can optimise and control the crystallisation environment, hence achieving the 123 
required crystal shape distribution. 124 
 125 
 126 
 127 
 128 
 129 
 130 
 131 
 132 
 133 
 134 
 135 
 136 
 137 
 138 
 139 
 140 
 141 
 142 
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Figure 1. Schematic of a framework for digital design of crystals with pre-defined size/shape and 164 
their distributions using MPB modelling. Note that {h1k1l1}, {h2k2l2} and {h3k3l3} are the Miller 165 
Indices of the crystal and x1, x2 and x3 are the corresponding normal distances from the individual 166 
faces to the centre of the crystal, ) and t are the number population density function of crystals and 167 
crystallisation processing time, respectively. 168 
 169 
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2.2 MPB Model Formulation 171 
The general PB model formulation to describe particulate systems with internal and external variables 172 
can be found in literature (e.g., (Hulburt and Katz, 1964, Ramkrishna and Mahoney, 2002, Randolph 173 
and Larson, 1988)). In this study, the MPB methodology identifies and defines the normal distances 174 
from faces ({h1k1l1}, {h2k2l2} and {h3k3l3}) to the crystal centre as three independent dimension 175 
variables (x1, x2, x3), respectively, as shown in Figure 1. The PB equation for seeded batch cooling 176 
crystallisation processes in a well-mixed batch crystalliser without nucleation, agglomeration and 177 
breakage to simplify the case study of MPB for pharmaceutical crystallisation can be written as (e.g., 178 
(Ma and Roberts, 2018, Ma et al., 2008, Marchal et al., 1988, Puel et al., 2003)): 179 ଵ௏೅ሺ௧ሻ డడ௧ ሾȰሺݔଵǡ ݔଶǡ ݔଷǡ ݐሻ்ܸ ሺݐሻሿ ൅ డడ௫భ ሾȰሺݔଵǡ ݔଶǡ ݔଷǡ ݐሻܩଵሺݔଵǡ ݐሻሿ ൅ డడ௫మ ሾȰሺݔଵǡ ݔଶǡ ݔଷǡ ݐሻܩଶሺݔଶǡ ݐሻሿ ൅180 డడ௫య ሾȰሺݔଵǡ ݔଶǡ ݔଷǡ ݐሻܩଷሺݔଷǡ ݐሻሿ ൌ  ?                        (1) 181 
where VT is the total volume of solution (or slurry after seeding) in a crystalliser; t is the processing 182 
time; ) is the number population density function of crystals; Gi (i = 1, 3) is the growth rate in the xi 183 
(i = 1, 3) direction. The corresponding initial condition is the size/shape distribution as a function of 184 
the three variables (x1, x2, x3) at the time of zero, i.e., Ȱሺݔଵǡ ݔଶǡ ݔଷǡ ݐሻȁ௧ୀ଴ ൌ  ?. For a batch cooling 185 
crystallisation process, the boundary conditions for Eq. (1) are Ȱ൫ݔଵǡ௜ǡ ݔଶǡ௝ǡ ݔଷǡ௞ǡ ݐ൯ȁ௜ୀଵ୭୰ேభ ൌ  ? (j = 186 
1, N2; k = 1, N3), Ȱ൫ݔଵǡ௜ǡ ݔଶǡ௝ǡ ݔଷǡ௞ǡ ݐ൯ȁ௝ୀଵ୭୰ேమ ൌ  ?  (i = 1, N1; k = 1, N3) and 187 Ȱ൫ݔଵǡ௜ǡ ݔଶǡ௝ǡ ݔଷǡ௞ǡ ݐ൯ȁ௞ୀଵ୭୰ேయ ൌ  ? (i = 1, N1; j = 1, N2), where N1, N2, N3 are the total number of 188 
classes for the (x1, x2, x3) size domains (see the Supplementary materials (S3) for the definitions of 189 
other parameters). It is worth to note that three dimensions (x1, x2, x3) are not Cartesian coordinates, 190 
hence they are not perpendicular to each other. Furthermore, depending on the number of independent 191 
crystal faces identified, the MPB techniques can generate the MPB equation with the corresponding 192 
number of dimensions. The growth rates of individual faces such as ({h1k1l1}, {h2k2l2} and {h3k3l3}) 193 
can be obtained through fitting with measured crystal growth data (see more detail in the 194 
Supplementary materials (S2)). The discretisation method can be used to form multi-dimensional 195 
ordinary differential equations for their solution with a standard solver such as the Runge-Kutta-196 
Fehlbergh solver (see further details in the Supplementary materials (S3) and Section 3.2). 197 
 198 
 199 
 200 
 201 
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3. MPB Modelling of D-pABA Crystallised from Ethanolic Solutions  202 
3.1 Materials and Solute-Solvent System 203 
The organic compound, para aminobenzoic acid, provides an important representative compound for 204 
fundamental study (Rosbottom et al., 2017, Rosbottom, 2016, Toroz et al., 2015, Rosbottom et al., 205 
2015, Sullivan et al., 2014, Nguyen et al., 2014). The D polymorphic form, D-pABA, can be readily 206 
crystallised from ethanol solvent in a 0.5L batch crystalliser using a seeded cooling process. The 207 
pABA molecular structure shows that it consists of a phenyl ring with a carboxylic acid group and an 208 
amino group in the para position (Rosbottom et al., 2015). Through crystallographic studies and 209 
molecular modelling, the D-pABA crystal morphology (Figure 2) can be characterised by 8 stable 210 
crystal faces (2 {101}, 2 {10-1} and 4 {011} faces) in a monoclinic crystal structure with the space 211 
group P21/n (Rosbottom et al., 2015). The D-pABA crystal structure comprises two molecules in the 212 
asymmetric unit and eight molecules in the unit cell with cell dimensions: a = 18.55 Å, b = 3.86 Å, c 213 
= 18.64 Å and E = 93.56o (a, b, c and E are the unit cell parameters) The intermolecular packing 214 
arrangement within the structure is dominated by the formation of two non-equivalent OH···O H-215 
bonding dimers between neighbouring carboxylic acid groups, and also by ʌ - ʌVWDFNLQJLQWHUDctions 216 
created by the head to heat stacking motif of the pABA molecules along the b direction. Overall, the 217 
D form of pABA crystal is observed to have a needle-like or lath-like morphology elongated along 218 
the b-crystallographic axis which is a typical crystal shape for many pharmaceutical solids. Further 219 
detail can be found in literature (Rosbottom et al., 2015, Toroz et al., 2015). 220 
Based on the crystal morphology of D-pABA (Figure 2) and the definition of independent variables 221 
for MPB modelling in Section 2, the three variables for MPB simulation of D-pABA crystallisation 222 
from ethanol can be determined as shown in Figure 2. 223 
 224 
 225 
 226 
 227 
 228 
 229 
 230 
 231 
 232 
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 233 
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 236 
 237 
 238 
 239 
 240 
 241 
 242 
 243 
Figure 2. The D-pABA crystal shape (single crystal image from (Rosbottom, 2016) and prediction 244 
by VisualHABIT (Clydesdale et al., 1991, Clydesdale et al., 1996, Pickering et al., 2017)) and the 245 
definitions of the three independent dimension variables (x1, x2, x3) perpendicular to its three dominant 246 
crystal faces {101}, {10-1}, {011}  for MPB modelling. 247 
 248 
The solubility of D-pABA in ethanol solvent were obtained from literature (Toroz et al., 2015, 249 
Rosbottom et al., 2017) using an isothermal technique. The experiments were carried out at the 1.5 250 
ml scale with 300 rpm micro magnetic-bar stirring using an Avantium Crystal16 unit.  251 
 The facet crystal growth rates in the x1, x2 and x3 face directions of D-pABA growing in ethanol were 252 
measured by an optical microscopy in a crystal growth cell (Toroz et al., 2015), with more detail to 253 
be found in (Toroz et al., 2015, Nguyen et al., 2014). 254 
  255 
3.2 Crystallisation Environment and MPB Solution 256 
The obtained three dimensional MPB equation, together with available solubility and faceted growth 257 
rate equations based on single crystal experimental data from Toroz et al. (Toroz et al., 2015), was 258 
solved with the following operating conditions: cooling rate (CR) of 0.5oC/min,  saturation 259 
concentration of 0.222 kg/kg (saturated temperature of 45oC), seeding point of 20.5oC with the 260 
corresponding supersaturation, S, (= solute concentration (C) / solubility) of 1.5, seed loading of 0.1% 261 
(by mass), and seed mean x1, x2 and x3 of 22, 37 and 58 Pm. Using the above operating conditions as 262 
X1 
 
x2 
x3 
 (a)                                   
 (b)                                            
 {011}                              
 {101}                              
 {10-1}                             
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a base case (green coloured in Table 1), further simulations were carried out to investigate the effect 263 
of different operating conditions (Table 1) on the crystal size/shape evolution of D-pABA 264 
crystallisation, including different CR of 0.05 ± 1.5oC/min, various seeding temperatures (Tseeds) of 265 
20.5 ± 39.0oC (corresponding to supersaturation at the seeding points (Sseeds) of 1.5 ± 1.1), different 266 
seed loadings (Xseeds) of 0.1 ± 5.0%, initial mean size/shape of seeds (Mseeds  (ݔҧଵǡ ݔҧଶǡ ݔҧଷ) are the mean 267 
sizes of variable (x1, x2, x3) and the corresponding (ߪ௫భ ǡ ߪ௫మ ǡ ߪ௫య) are the standard deviations), and 268 
other special operating conditions such as broken seeds. All of the simulations were terminated when 269 
the supersaturation reached to 1.01, indicating that crystal growth in all face directions became close 270 
to zero, hence any further crystallisation process would not vary the size/shape distributions, yield of 271 
the final products. 272 
 273 
Table 1. Operating conditions used for MPB simulations 274 
Cooling rate (CR) 
CR 
(oC/min) 
Saturation 
concentration 
C (kg/kg) 
Saturation 
T (oC) 
Seeding 
point ± 
Tseeds (oC) 
Sseeds 
(-) 
Xseeds 
(% 
mass) 
  Mseeds 
(ݔҧଵǡ ݔҧଶǡ ݔҧଷ)  
(Pm) 
Seeds standard 
deviations - ሺߪ௫భ ǡ ߪ௫మ ǡ ߪ௫య) (Pm) 
0.05 0.222 45 20.5 1.5 0.1 22, 37, 58 8, 8, 8 
0.5 0.222 45 20.5 1.5 0.1 22, 37, 58 8, 8, 8 
1.0 0.222 45 20.5 1.5 0.1 22, 37, 58 8, 8, 8 
1.5 0.222 45 20.5 1.5 0.1 22, 37, 58 8, 8, 8 
Seeding point (Tseeds or Sseeds) 
0.5 0. 222 45 39.0 1.1 0.1 22, 37, 58 8, 8, 8 
0.5 0. 222 45 33.7 1.2 0.1 22, 37, 58 8, 8, 8 
0.5 0. 222 45 28.9 1.3 0.1 22, 37, 58 8, 8, 8 
0.5 0. 222 45 24.7 1.4 0.1 22, 37, 58 8, 8, 8 
0.5 0. 222 45 20.5 1.5 0.1 22, 37, 58 8, 8, 8 
Seed loading (Xseeds) 
0.5 0. 222 45 20.5 1.5 0.1 22, 37, 58 8, 8, 8 
0.5 0. 222 45 20.5 1.5 0.5 22, 37, 58 8, 8, 8 
0.5 0. 222 45 20.5 1.5 1.0 22, 37, 58 8, 8, 8 
0.5 0. 222 45 20.5 1.5 2.0 22, 37, 58 8, 8, 8 
0.5 0. 222 45 20.5 1.5 5.0 22, 37, 58 8, 8, 8 
Seed mean shape (Mseeds) 
0.5 0. 222 45 20.5 1.5 0.1 22, 37, 58 8, 8, 8 
0.5 0. 222 45 20.5 1.5 0.1 22, 27, 40 8, 8, 8 
0.5 0. 222 45 20.5 1.5 0.1 22, 27, 131 8, 8, 8 
 275 
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The typical seeds distributions for perfect and broken crystals are shown in Figure 3. With fixed mean 276 
sizes, Mseeds, (ݔҧଵǡ ݔҧଶǡ ݔҧଷ) of (22, 37, 58µm) and standard deviationsሺߪ௫భ ǡ ߪ௫మ ǡ ߪ௫య) of (8, 8, 8µm), a 277 
Gaussian distribution of seeds crystals, Ȱሺݔଵǡ ݔଶǡ ݔଷǡ  ?ሻ, can be obtained using the pre-defined seeds 278 
loading (Xseeds). With the same amount of seed loading, the case with broken seeds (Figure 3b) has 279 
higher number of crystals. In Figure 3b, the bottom horizontal axis, z, is based on the face {011} at 280 
the side without breakage, i.e. the right side of the crystals, whilst the top horizontal axis is based on 281 
the broken face (010). 282 
 283 
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Figure 3. Typical seeds shape/size distributions: (a) perfect seed crystals, (b) broken seed crystals at 304 
the mean normal distances of faces {101} and {10-1}, i.e. x1 and x2. Note that the three values in the 305 
brackets in a) represent the normal distances of faces {101}, {10-1} and {011}, and the first three 306 
values in the brackets in b) represent the normal distances of faces {101}, {10-1} and {011} with the 307 
fourth one for the broken face (010). 308 
 309 
With the MPB equation and discretisation method described in the Section 2.2 and Supplementary 310 
materials (S3), respectively, the (x1, x2, x3) 3D domain of normal distances was discretised into (70, 311 
70, 70) classes over the size ranges of three normal distances. The discretised MPB equations, 312 
together with a Gaussian-type initial distribution of seeds size/shape (as shown in Figure 3), and the 313 
other operating conditions (as listed in Table 1), were solved using the Runge-Kutta-Fehlbergh 4th/5th-314 
order solver (Shampine and Watts, 1977) with an automatic time-step control to obtain the evolution 315 
of normal distances in three face directions. 316 
   317 
4. Results and Discussion  318 
4.1 Solubility and Facet Growth Rates 319 
The data obtained from literature (Toroz et al., 2015) were analysed to obtain the following solubility 320 
equation: 321 ܥכ ൌ ݁ቀିభఱలఴ೅ ାଶǤଷଷଷଷቁ          (2) 322 
where T is the solution temperature (oC). 323 
The experimental data of face-specific experimental data of growth rates of single crystals in a growth 324 
cell was collected by Toroz et al. (Toroz et al., 2015). The corresponding growth cell setup can be 325 
found in Nguyen et al. (Nguyen et al., 2014, Turner et al., 2019). Based on the experimental data 326 
(Toroz et al., 2015) and the face-specific growth kinetics described in the Supplementary materials 327 
(S2), the fit of growth rate in the face direction of {011} as a function of supersaturation was found 328 
to correspond to an RIG mechanism (r = 1 in Eq. (S.1)) even at low supersaturations. The 329 
corresponding facet growth rate of face {011}, G3, is as follows: 330 
 ܩଷ ൌ ܩሼ ? ? ?ሽ ൌ ௌିଵǤ଴଴ଵହ଼Ǥ଺ହൈଵ଴షరା భమǤబൈభబఱൈሺೄషభǤబబభఱሻబ       (3) 331 
From Eq. (3), it can be seen that the diffusion related term with a value of 8.65 u 10-4 is over 2 times 332 
magnitude larger than that for the surface integration term (5 u 10-6). Therefore the rate of crystal 333 
13 
 
growth of face {011} is diffusion limited by diffusion mass transfer (Camacho et al., 2016), i.e. the 334 
crystal growth is controlled by how fast the solute molecules in bulk solution diffuses from the bulk 335 
solution and across the solid/solution boundary layer for integrating with (growing on) the crystal 336 
face. From molecular modelling studies (Rosbottom et al., 2015, Toroz et al., 2015) WKH ʌ - ʌ337 
interactions dominate the growth on the {011} faces and the attachment of pABA molecules via the 338 
ʌ- ʌVWDFNLQJPRWLIPD\OHDGWRDVROLG-solid integration mechanism at the surface, hence any growth 339 
spirals present at this surface. Therefore the diffusion of molecules to the surface controls the growth 340 
of face {011}, as also indicated by Eq. (3). 341 
The fitting of the growth rate in the {10-1} face direction, G2, corresponds to a birth and spread (B&S) 342 
growth mechanism (Eq. (S.2)) with the following equation: 343 
 ܩଶ ൌ ܩሼ ? ?െ  ?ሽ ൌ ௌିଵǤ଴ଵଽǤହସൈଵ଴షయା భరǤబൈభబరൈሺೄషభǤబభሻషభȀలൈ೐ೣ೛ቀ బǤఱೄషభǤబభቁ                (4) 344 
As both the diffusion related term and surface integration term have similar values (see Eq. (4)), the 345 
diffusion (mass transfer) and surface integration have the similar effect on the crystal growth of face 346 
{10-1}. 347 
It was found that the growth of D-pABA crystals in the {101} face direction was too slow to measure 348 
directly and thus the {101} face growth rate, G1, was estimated from G2 based on the ratio of 349 
attachment energies between face {101}  and face {10-1} (Rosbottom et al., 2015). Hence 350 
 G1 = G{101} = 0.1 * G2                 (5) 351 
 352 
4.2 Base Case 353 
Figure 4 shows the simulated solution temperature, supersaturation, crystal concentration, mean 354 
normal distances (x1, x2, x3) for faces {101}, {10-1}, {011}, and the corresponding facet growth rates 355 
at a cooling rate (CR) of 0.5oC/min. The mean normal distance for face {011} increased rapidly with 356 
time as the face {011} is the fastest growing face from previous studies (Rosbottom et al., 2015, 357 
Toroz et al., 2015), while less growth happened in x direction.  358 
 359 
 360 
 361 
 362 
 363 
       (a)                                                    (b)                                                     (c) 
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      364 
Figure 4. Typical MPB predicted results with CR = 0.5oC/min: (a) solution temperature (T), 365 
supersaturation (S), crystal concentration (Cs), (b) evolution of mean normal distances (x1, x2, x3), and 366 
(c) facet growth rates (G1, G2, G3) in (x1, x2, x3) face directions. 367 
  368 
Figure 5 presents the typical shape distribution of D-pABA crystals in the final product with a fixed 369 
normal distance, x1, of 30.8Pm, and other two normal distances (x2, x3) varying from (45 Pm, 105 370 
Pm) to (163 Pm, 262 Pm). For each normal distances of (30.8, x2, x3), the corresponding crystals 371 
shape can be generated based on the definition in Figure 2(b). Therefore, the crystal shape and the 372 
number of crystals having this shape were plotted in Figure 5. It demonstrated that the simulated 373 
results can provide the accurate and full shape information of the whole population of the crystals. 374 
Similarly, the full shape information can be obtained from the simulation results at any individual 375 
crystallisation time. Therefore, the evolution map of crystal shape over the whole crystallisation 376 
process can be established. Some crystal mean shapes at different processing times are plotted in 377 
Figure 6. Due to the fast growth of face {011}, the D-pABA crystals became increasingly needle-like 378 
with time. The aspect ratio, X3/X2 (where X2 and X3 are the mean values of x2, x3 at a crystallisation 379 
time), increased from 2.2 (seeds) to 5.3, then reduced slightly to 4.8 (final products). This is due to 380 
that the faceted growth rates of face {011}, G3, and face {10-1}, G2, have a cross-over at the 381 
supersaturation of 1.18, i.e. with the further decrease of supersaturation from 1.18, G3 became smaller 382 
than G2. Similar tread was found for the aspect ratio, X3/X1 (where X1 is the mean value of x1), with a 383 
much faster increase against time due to that the x1 grew very slow. Therefore the aspect ratio (X3/X1) 384 
increases from 6 to over 30.   385 
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 386 
Figure 5. Typical shape distribution of D-pABA crystals with a fixed normal distance, x1, of 30.8 387 
Pm, and other two normal distances (x2, x3) varying from (45 Pm, 105 Pm) to (163 Pm, 262 Pm). 388 
Note that the values in the brackets are the three normal distances for the individual crystal habit faces 389 
(x1, x2, x3) in micrometres together with the number under the brackets which gives the number of 390 
crystals having this specified shape as defined by the normal distances. 391 
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 393 
Figure 6. MPB predicted mean shape evolution of D-pABA crystals crystallised from ethanol with 394 
CR = 0.5oC/min (Aspect ratios: U - X3/X2; c - X3/X1).  395 
 396 
4.3 Effect of Cooling Rate 397 
Figure 7 shows the evolution of supersaturation during crystallisation processes (Figure 7a), and the 398 
final shape/size and their corresponding aspect ratios under four cooling rates (Figure 7b). It can be 399 
seen that the supersaturation decrease with processing time is slower with higher cooling rate (Figure 400 
7a). As the supersaturation is defined as the ratio between solute concentration in the crystalliser at a 401 
given time (temperature) and the solubility of the solute-solvent system at the same given time 402 
(temperature), the evolution of supersaturation during a crystallisation process can be fast or slow 403 
depending on the balance of the solute concentration and solubility. In this study, the higher cooling 404 
rate led to faster decrease of solubility (due to the faster decrease of temperature) than the lower 405 
cooling rate. However, the decrease of solute concentration (due to crystal growth, hence consuming 406 
solute in the solution) does not necessarily follow the same decrease speed. Therefore, if the decrease 407 
of solute concentration is slower that the solubility, the combining effects could result in the slower 408 
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reduction of supersaturation with higher cooling rate. The final shape/size under various cooling rates 409 
was found to be similar and the corresponding aspect ratio (X3/X2) varied between 4.8 and 4.3 (Figure 410 
7b), which indicates that the variation of cooling rate may not be an effective tool to manipulate 411 
crystal size/shape of final products under the current operating conditions.  412 
   413 
Figure 7. (a) Supersaturation evolution during crystallisation processes and (b) final mean shape/size 414 
under different cooling rate (CR = 0.05oC/min ± dash green line; CR = 0.5oC/min ± red line; CR = 415 
1.0oC/min ± dash and dot blue line; CR = 1.5oC/min ± black line).  416 
 417 
Figures 8 and 9 illustrate the evolution of faceted growth rates and normal distances, respectively, 418 
during crystallisation processes in face direction of {101}, {10-1} and {011} under different cooling 419 
rates. The face-specific growth rates of the three faces decreased during the process with the speed of 420 
decrease being slower at higher cooling rate. The corresponding normal distances for all three faces 421 
increased faster with the higher cooling rate. By examining the final size/shape of D-pABA crystals 422 
with various cooling rates when supersaturation researched a value of 1.01 (hence no further 423 
crystallisation), the total crystallisation time, final temperature, total crystal mass (yield) and the fine 424 
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mean size/shape were obtained as shown in Table 2. The total crystal mass in Table 2 was obtained 425 
from ߩ௦  ?  ?  ? ൣܸ൫ݔଵǡ௜ǡ ݔଶǡ௝ ǡ ݔଷǡ௞൯Ȱ൫ݔଵǡ௜ǡ ݔଶǡ௝ ǡ ݔଷǡ௞൯൧ேయ௞ୀଵேమ௝ୀଵேభ௜ୀଵ , where ߩ௦ is the density of the crystal, 426 ܸ൫ݔଵǡ௜ǡ ݔଶǡ௝ǡ ݔଷǡ௞൯ is the volume of a crystal with normal distances of ൫ݔଵǡ௜ǡ ݔଶǡ௝ ǡ ݔଷǡ௞൯ calculated based 427 
on the crystals shape shown in Figure 2(b) and ൫ݔଵǡ௜ǡ ݔଶǡ௝ǡ ݔଷǡ௞൯, and the definitions of other variables 428 
can be found in the Supplementary materials (S3). With the increase of cooling rate from 0.05 to 429 
1.5oC/min in this study, the total process time is almost doubled with the corresponding final 430 
temperature being lowered from about 20oC to 8oC and the yield of D-pABA crystals being increased 431 
about 50%. Furthermore the final crystal size is about 40% larger with CR = 1.5oC/min than 432 
0.05oC/min though the variation of final crystal mean shape (aspect ratio) is not significant.  433 
 434 
 Figure 8. Evolution of faceted growth rates during crystallisation processes in face direction of (a) 435 
face {101}, (b) face {10-1} and (c) face {011} under different cooling rate (CR = 0.05oC/min ± dash 436 
green line; CR = 0.5oC/min ± red line; CR = 1.0oC/min ± dash and dot blue line; CR = 1.5oC/min ± 437 
black line). 438 
     439 
Figure 9. Evolution of normal distances during crystallisation processes in face direction of (a) face 440 
{101}, (b) face {10-1} and (c) face {011} under different cooling rate (CR = 0.05oC/min ± dash green 441 
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line; CR = 0.5oC/min ± red line; CR = 1.0oC/min ± dash and dot blue line; CR = 1.5oC/min ± black 442 
line). 443 
 444 
Table 2. MPB modelling results of D-pABA crystallised from ethanol under different CR 445 
CR 
(oC/min) 
Process 
Time (s) 
Final S 
(-) 
Final T 
(oC) 
Final mean (x1, 
x2, x3) (Pm) 
Total crystal 
±  mass (g) 
0.05 270 1.01 20.3 52, 340, 1174 50.7 
0.5 300 1.01 18.0 55, 368, 1261 55.0 
1.0 340 1.01 14.8 58, 409, 1393 60.5 
1.5 495 1.01 8.2 66, 495, 1539 73.1 
 446 
 447 
4.4 Effect of Seeding Temperature 448 
In order to investigate the effect of seeding temperature on seeded cooling crystallisation of D-pABA 449 
in a batch crystalliser, the seeding temperature (Tseeds) was varied from 20.5oC to 39.0oC, which 450 
corresponds to seeding supersaturation (Sseeds) decreasing from 1.5 to 1.1. The supersaturation 451 
evolution during crystallisation processes and the final mean shape/size under different seeding 452 
temperature (or seeding supersaturation) are plotted in Figure 10. With a fixed cooling rate of 453 
0.5oC/min, as shown in Figure 10a, the supersaturation decreased much faster with lower Tseeds (or 454 
higher Sseeds) than higher Tseeds (or lower Sseeds). The total process time for various Tseeds (or Sseeds) did 455 
not show significant variation (Table 3). From Figure 10b, it is clear that final mean crystal size with 456 
higher Tseeds (or lower Sseeds) is smaller in size and less needle-like in shape (or lower aspect ratio) 457 
(Table 3). When varying of Sseeds from 1.1 to 1.5, the aspect ratio (X3/X2) was increased from 2.5 to 458 
4.8 (Figure 10b). 459 
For the evolution of face-specific growth rates and normal distances (x1, x2, x3), respectively, during 460 
crystallisation processes in face direction of {101}, {10-1} and {011} under different Tseeds (or Sseeds), 461 
the supersaturation decreased slower with higher Tseeds (or lower Sseeds), hence the facet growth rates 462 
for the three individual faces followed the same trend (Figure S.1 in Supplementary materials (S4)). 463 
Correspondingly, the normal distances (x1, x2, x3) increased against crystallisation time much faster 464 
with lower Tseeds (or higher Sseeds) and also larger actual normal distances (Figure S.2 in 465 
Supplementary materials (S4)). Furthermore, this is more significant for the evolution of normal 466 
distance of face {011}, i.e. x3. As a result, the higher growth rates and bigger actual normal distances 467 
with lower Tseeds (or higher Sseeds) produced much higher yield as shown in Table 3. Therefore, it is 468 
not optimal to select an experiment with higher Tseeds (or lower Sseeds) as the resultant yield would be 469 
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unacceptably low albeit from these conditions the final crystal shape would be expected to be less 470 
needle-like (smaller aspect ratio). 471 
  472 
Figure 10. (a) Supersaturation evolution during crystallisation processes and (b) final mean 473 
shape/size under different seeding temperature (Tseeds) (or supersaturations (Sseeds)) (Tseeds = 20.5oC 474 
(or Sseeds = 1.5) ± dash red line; Tseeds = 24.7oC (or Sseeds = 1.4) ± thin black line; Tseeds = 28.9oC (or 475 
Sseeds = 1.3) ± dash and dot blue line; Tseeds = 33.7oC (or Sseeds = 1.2) ± black line; Tseeds = 39.0oC (or 476 
Sseeds = 1.1) ± dot green line). 477 
 478 
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Table 3. MPB modelling results of D-pABA crystallised from ethanol under different seeding 483 
temperature (Tseeds) (or seeding supersaturation (Sseeds)) 484 
Seeding point 
± Tseeds (oC) 
Sseeds 
(-) 
Time 
(s) 
Final S 
(-) 
Final T 
(oC) 
Final means 
(x1, x2, x3) (Pm) 
Total crystal 
± mass (g) 
39.0 1.1 290 1.01 36.55 37.9, 191, 376 17.5 
33.7 1.2 260 1.01 31.5 39.3, 210, 568 28.5 
28.9 1.3 250 1.01 26.85 42.1, 239, 744 38.0 
24.7 1.4 265 1.01 22.47 46.4, 289, 961 46.5 
20.5 1.5 300 1.01 18.0 55, 368, 1261 55.0 
 485 
 486 
4.5 Effect of Seed Loading 487 
Figure 11 shows the evolution of supersaturation during crystallisation processes (Figure 11a), and 488 
the final mean shape/size and their corresponding aspect ratios (Figure 11b) under five different seed 489 
loadings. With higher seed loading under the same Gaussian-like size/shape distribution (same mean 490 
values and same standard deviations), the total number of crystals becomes proportionally larger. 491 
Therefore, the total crystal surface area for crystal growth is predicted to increase with the increase 492 
of seed loading, hence solute concentration reduces faster, leading to faster supersaturation decrease 493 
(Figure 11a). As the total number of seeds is higher with higher seed loading, the solute available for 494 
each seed is less accordingly. Therefore, as shown in Figure 11b, the final mean crystal is smaller in 495 
size and also less needle-like in shape (or aspect ratio). When seed loading increases from 0.1% to 496 
2.0% (by mass), the MPB simulation results show that the aspect ratio (X3/X2) decreases almost 497 
linearly with a slope of -0.4 and intercept of 4.8 (Figure 11b). 498 
The evolution of faceted growth rates (Figure S.3 in Supplementary materials (S5)) and face normal 499 
distances (Figure S.4 in Supplementary materials (S5)) during crystallisation processes on the {101}, 500 
{10-1} and {011} faces under different seed loadings demonstrated that as the increase of seed 501 
loading resulted in the faster decrease of supersaturation (Figure 11a), the faceted growth rates (G1, 502 
G2, G3) also decrease faster (Figure S.3) with the corresponding normal distances being in slower 503 
increase (Figure A.4). The final temperature and yield did not have significant variation for the 504 
simulated range of seed loadings (Table 4). However, the crystal size of final product is predicted to 505 
be smaller with less needle-like in shape when seed loading is increased. Therefore, seed loading can 506 
be an effective tool for optimising and controlling crystal size/shape distribution using MPB 507 
approach. 508 
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  509 
Figure 11. (a) Supersaturation evolution during crystallisation processes and (b) final mean 510 
shape/size under different seed loading (Xseeds) (Xseeds = 0.1% ± dash red line; Xseeds = 0.5% ± thin 511 
black line; Xseeds = 1.0% ± dash and dot blue line; Xseeds = 2.0% ± black line; Xseeds = 5.0% ± dot green 512 
line).  513 
 514 
Table 4. MPB modelling results of D-pABA crystallised from ethanol under different seed loading 515 
(Xseeds) 516 
Xseeds (% 
mass) 
Time 
(s) 
Final S 
(-) 
Final T 
(oC) 
Final means 
(x1, x2, x3) (Pm) 
Total crystal 
± mass (g) 
0.1 270 1.01 18.0 55, 368, 1261 55.0 
0.5 220 1.01 18.7 43.6, 261, 858 54.5 
1.0 205 1.01 18.8 42.1, 241, 783 55.0 
2.0 205 1.01 18.8 40.7, 224, 689 56.3 
5.0 215 1.01 18.7 39.3, 215, 616 57.4 
 517 
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4.6 Effect of Seed Mean Shape 520 
To investigate the effect of seed mean shape on crystal size/shape distribution during D-pABA 521 
crystallisation process, three different mean shape were used for establishing seeds size/shape 522 
distribution (e.g. Figure 3a): mean normal distances (x1, x2, x3) of (22, 27, 6 Pm), (22, 27, 40 Pm) and 523 
(22, 27, 131 Pm) with fixed standard deviations of (ߪ௫భ ǡ ߪ௫మ ǡ ߪ௫య) = 8 Pm.  Figure 12 shows the 524 
supersaturation evolution during crystallisation processes and the final mean shape/size under 525 
different seed mean shape. With more needle-like seeds, the total number of seeds (under the same 526 
seed loading) was found to be slightly smaller, hence leading to slower decrease of supersaturation 527 
(Figure 12a). However, the simulated final crystal size is found to be bigger with slightly higher 528 
aspect ratio (Figure 12b). Similarly, the faceted growth rates follow the same trend of decrease (Figure 529 
S.5 in Supplementary materials (S6)) and the normal distances (x1, x2, x3) have the similar trend of 530 
increase with crystallisation time (Figure S.6 in Supplementary materials (S6)). The final temperature 531 
and yield do not present significant variation for the three seed mean shape (Table 5).  532 
Figure 12. (a) supersaturation evolution during crystallisation processes and (b) final mean shape/size 533 
under different seed mean shape (Mseeds) with standard deviations of ሺߪ௫భ ǡ ߪ௫మ ǡ ߪ௫య) = 8 Pm (Mseeds = 534 
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(22, 27, 6 Pm) ± red line; Mseeds = (22, 27, 40 Pm) ± dash green line; Mseeds = (22, 27, 131 Pm) ± dash 535 
and dot black line). 536 
 537 
Table 5. MPB modelling results of D-pABA crystallised from ethanol under different seed mean 538 
shape (Mseeds) 539 
Mseeds (x1, 
x2, x3) (Pm) 
Seeds standard 
deviations 
(ߪ௫భ ǡ ߪ௫మ ǡ ߪ௫య) (Pm) Time (s) Final S (-) Final T (oC) Final means (x1, x2, x3) (Pm) Total crystal ± mass (g) 
22, 27, 6 8, 8, 8 285 1.01 18.1 50.7, 320, 1119 54.6 
22, 27, 40 8, 8, 8 280 1.01 18.18 49.3, 308, 1009 54.4 
22, 27, 131 8, 8, 8 330 1.01 17.76 57.9, 400, 1501 55.2 
 540 
 541 
4.7 Effect of Broken Seeds 542 
Theoretically seeds may be treated as prefect crystals with the required size/shape distribution. 543 
However, in practice, seeds are usually collected from small scale and well-controlled crystallisation 544 
processes, then followed by the necessary washing, filtration and drying, all processes which might 545 
expect to provide some extent of breakage/damage to the obtained seeds. In order to obtain seeds with 546 
the required size, milling/sieving processes may be used, which understandably will generate broken 547 
seeds at very high extent. In this section, the MPB model was used to simulate the behaviour of the 548 
broken seeds during crystallisation processes. All operating conditions are as the same as those from 549 
the base case (section 4.2) with the size/shape distribution of broken seeds as shown in Figure 3b. 550 
The broken face (010) should be rough with most possibly an RIG growth mechanism. In this study, 551 
the facet growth rate of face (010) was estimated to be two times of that for face {011}, G3. It should 552 
be noted that the more accurate growth rate and growth mechanism for the broken face (010) are 553 
needed through the use of molecular modelling and/or experimental measurements. 554 
Figure 13 shows the solution temperature, supersaturation, solute concentration and solid 555 
concentration during crystallisation processes with perfect seeds or broken seeds. With the same 556 
cooling rate (0.5oC/min), supersaturation with broken seeds decreased slightly faster, hence reaching 557 
the supersaturation value of 1.01 earlier (~ 28s). Correspondingly, solute concentration dropped at a 558 
higher speed and solid concentration increased faster.  559 
Figures 14 presents the faceted growth rates in the directions of faces {101}, {10-1} and {011}, and 560 
also broken face (010) with its trajectory, and the corresponding evolution of normal distances for the 561 
mentioned four faces. MPB simulations revealed that the broken face (010) grew very fast, then 562 
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disappeared after about 15 s (Figure 14b). The facet normal distances, in particular x3 for face {011}, 563 
increased slower at the late stage of the crystallisation process with broken seeds. The main 564 
contributors are both broken seeds (shorter in size and higher number of seeds) and the faster decrease 565 
of supersaturation (also faster decrease of growth rate of face {011} (Figure 14a)).  566 
 567 
Figure 13. Solution temperature (T and Tbk), supersaturation (S and Sbk), solute concentration (c and 568 
cbk) and solid concentration (Cs and Csbk) during crystallisation processes with the operating 569 
conditions of the base case and broken seeds (Symbols ± perfect seed crystals; Lines ± broken seed 570 
crystals; bk ± broken seeds).  571 
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(b) 
(a) 
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Figure 14. Faceted growth rates (a) and Normal distances (b) in the face directions of face {101} 573 
(solid line ± perfect seed crystals; U ± broken seed crystals), face {10-1} (dot line ± perfect seed 574 
crystals;  ± broken seed crystals) and face {011} (Dash line ± perfect seed crystals;  ± broken 575 
seed crystals), and also broken face (010) (dash and dots line) with its trajectory (c) during 576 
crystallisation processes with the operating conditions of the base case. 577 
 578 
Figures 15 and 16 present the evolution of aspect ratios (X3/X2, X3/X1, X2/X1) during crystallisation 579 
process for both prefect seeds and broken seeds, and crystal mean shape evolution and aspect ratios 580 
at several typical time points for broken seeds, respectively. Note that X1, X2 and X3 are the mean 581 
values of x1, x2, x3 at a crystallisation time. The aspect ratios (X3/X2 and X3/X1) increased fast to the 582 
values for prefect seeds after about 15 s (Figure 15) with the broken face (010) being disappearance 583 
(Figure 16). 584 
 585 
Figure 15. Evolution of aspect ratios during crystallisation process with prefect and broken seeds. 586 
 587 
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                 588 
Figure 16. Crystal mean shape evolution and aspect ratios at some typical time instances (0, 5, 10, 589 
15, 20, 50, 100, 200, 300 s). Note that the broken face (010) grew fast and disappeared in about 15 s.  590 
 591 
5. Conclusions  592 
In this study, the MPB models were applied for simulating pharmaceutical crystallisation processes 593 
as illustrated through a case study of D-pABA crystals crystallised from ethanolic solution under a 594 
wide-range of operating conditions notably cooling rate, seeding temperature (seeding 595 
supersaturation), seed loading, seeds shape/size (including broken seeds). The MPB simulations 596 
captured the shape-dependent behaviour of the crystallisation processes under these operating 597 
conditions with the effect of defining the impact of these processing variables on the crystal size/shape 598 
distribution and their evolution. 599 
 ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?   ? ? ?Ɛ 
) 
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Within the operating conditions used for MPB simulations, faster cooling was shown to increase the 600 
crystallisation time to reach solution equilibrium conditions, i.e. S = 1, with the corresponding 601 
finishing solution temperature being much lower, hence leading to higher yield and larger final crystal 602 
size. Although higher seeding temperatures (hence lower seeding supersaturations) was found to 603 
produce less needle-like D-pABA crystals, the yield was much lower than that at lower seeding 604 
temperatures. On the other hand, higher seed loading was found to generate smaller sized crystals 605 
which were less needle-like in shape while having very similar yields. This indicated that seed loading 606 
could be a useful control variable for using MPB to obtain the pre-desired crystal size/shape 607 
distribution. For the case with broken seeds, the fractured seed surfaces were found to grow fast and 608 
hence disappear from the external morphology during the crystallisation process. Such simulations 609 
could have wide applications in pharmaceutical industry mindful that seeds used often exhibit some 610 
kind of breakage and/or damage during seed preparation processes, e.g. through milling. 611 
Further research should include the consideration of the effect of primary nucleation (i.e., without 612 
seeds) and together with that of secondary nucleation through surface breeding from seeds, face-613 
specific crystal agglomeration and breakage into the MPB model. This will involve first-principle 614 
based research on crystal morphology and surface chemistry, solid/solution interface (including the 615 
interactions of crystal-crystal, crystal-solute and crystal-solvent), solution chemistry, etc. Through 616 
these, combining the MPB model with computational fluid dynamics for crystalliser hydrodynamics 617 
and multi-zonal modelling will form a powerful digital design framework for pharmaceutical 618 
crystallisation to manufacture crystals with pre-desired properties, hence delivering targeted 619 
medicines. 620 
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Supplementary Materials 703 
This supplementary provides the mini-review of population balance (PB) models (S1), face-specific 704 
crystal growth kinetics (S2), the solution method of morphological PB (S3) and the additional 705 
simulation results of the evolution of face-specific growth rates and normal distances under different 706 
seeding temperature (S4), seed loading (S5) and seed mean shape (S6), and the references for 707 
supplementary materials (S7). 708 
 709 
S1. Mini-review of PB models 710 
For modelling the evolution of a population of crystals during crystallisation processes, one-711 
dimensional (1D) population balance (PB) approach (e.g., (Alvarez and Myerson, 2010, Caillet et al., 712 
2007, Fevotte et al., 2007, Garside, 1985, Gerstlauer et al., 2006, Hounslow et al., 2005, Li et al., 713 
2013, Liu and Li, 2014, Marchal et al., 1988, Menon et al., 2005, Patience et al., 2004, Rawlings et 714 
al., 1992, Temmel et al., 2016, Ulbert and Lakatos, 2005, Ward et al., 2006)), using a characteristic 715 
size, such as length (e.g., (Vetter et al., 2014, Ward et al., 2011, Zhang and Doherty, 2004)), diameter 716 
or radius of a volume equivalent sphere (e.g., (Marchal et al., 1988)) to simplify a faceted crystal, 717 
was used and still being used widely. Two-dimensional (2D) PB method was developed to account 718 
for needle-/rod-/plate-like crystals (e.g., (Briesen, 2009, Gunawan et al., 2004, Ma et al., 2007, 719 
Oullion et al., 2007, Puel et al., 2003a, Puel et al., 2003b, Ramkrishna and Mahoney, 2002, Sato et 720 
al., 2008, Shi et al., 2006)), whilst the introducing a volumetric shape factor into the 1D (or 2D) PB 721 
is to more accurately represent the crystal volume (Zhang and Doherty, 2004). However, using a 1D 722 
PB with the assumptions that all crystal faces have the same surface chemistry, growth mechanism 723 
and a constant relative growth rate ratio amongst all faces, the evolution of crystal size and shape 724 
could be represented (e.g., Doherty and co-workers (Lovette et al., 2008, Zhang and Doherty, 2004, 725 
Kuvadia and Doherty, 2013)). Critically, a 1D PB assumes that the crystal morphology does not 726 
change during growth, i.e. that the ratio of the growth rates between the different faces is constant. 727 
The aspect was first addressed by Ma et al. (Ma et al., 2008), followed by other researchers (e.g., 728 
(Borchert et al., 2009, Borchert and Sundmacher, 2012, Chakraborty et al., 2010, Kwon et al., 2013, 729 
Kwon et al., 2014, Liu et al., 2013, Liu et al., 2010b, Liu et al., 2010a, Ma et al., 2016, Ma and 730 
Roberts, 2018, Ma and Wang, 2008, Ma and Wang, 2012, Wan et al., 2009, Wang and Ma, 2009, 731 
Wang et al., 2008, Majumder and Nagy, 2013, Kuvadia and Doherty, 2013)). A crystal has its face 732 
forms identified as {hkl}. For a cubic crystal, it only has one form but 6 faces. For a potash alum 733 
crystal, it has 3 forms but 24 faces. The MPB uses crystal morphology to identify crystal forms with 734 
each form being treated as an independent variable (crystal face-to-centre distance) and the total 735 
33 
 
number of forms determines the number of dimensions of the MPB equation. It can be assumed that 736 
the faces of each form have the same surface chemistry, growth mechanism/rate and also other 737 
physical/chemical properties. See more detail in e.g. (Ma et al., 2008). The MPB not only provides a 738 
direct tool for optimisation and control of both final crystal size and shape but enables control of the 739 
particle properties and processing. 740 
 741 
S2. Face-specific crystal growth kinetics 742 
The kinetics of a defined crystal growth interface as a function of supersaturation can generally be 743 
described by a number of well-known models including power law (Garside, 1985), birth & spread 744 
(B&S) and Burton-Cabrera-Frank (BCF) models (Burton et al., 1951). During crystallisation 745 
processes in a crystal growth cell and other crystallisers, crystal growth rate is very much a two-step 746 
kinetic process encompassing a balance between the incorporation of growth units onto the crystal 747 
surface and the diffusion by mass transfer of the growth units within the bulk of the solution (Mullin, 748 
2001, Camacho et al., 2017). The effect of heat transfer on growth rate was also included by 749 
(Mersmann et al., 2002). Therefore both factors need to be considered when determining the growth 750 
mechanism and can be modelled using the followings (Mullin, 2001, Camacho et al., 2017): 751 ܩ௣௢௪௘௥ ൌ ௌିௌ೎ೝ೔೟ഐೞೖಾ೅಴כಾೞା భೖಸ൫ೄషೄ೎ೝ೔೟൯ೝషభ       (S.1) 752 ܩ஻Ƭௌ ൌ ௌିௌ೎ೝ೔೟ഐೞೖಾ೅಴כಾೞା భೖಸ൫ೄషೄ೎ೝ೔೟൯షభȀల೐ೣ೛ቀಲభȀ൫ೄషೄ೎ೝ೔೟൯ቁ     (S.2) 753 ܩ஻஼ி ൌ ௌିௌ೎ೝ೔೟ഐೞೖಾ೅಴כಾೞା భೖಸ൫ೄషೄ೎ೝ೔೟൯೟ೌ೙೓ቀಲమȀ൫ೄషೄ೎ೝ೔೟൯ቁ      (S.3) 754 
Where Gpower, GB&S and GBCF are the growth rates linking to the power law (Garside, 1985), B&S 755 
(Burton et al., 1951) and BCF (Burton et al., 1951) models; S is supersaturation defined by the ratio 756 
between the solute concentration at a solution temperature and the solubility at the same temperature; 757 
Scrit is a critical value of supersaturation; kG is the growth rate constant; r is the growth exponent; A1 758 
and A2 are the thermodynamic parameters; Us is the solute density; kMT is the coefficient of mass 759 
transfer within the bulk of the solution; Ms is the solute molecular weight; C* is the equilibrium 760 
concentration (solubility). The term ఘೞ௞ಾ೅஼כெೞ in Eqs. (S.1 ± S.3) can be treated as a fitting parameter. 761 
In Eq. (S.1), if r = 1, it corresponds to a rough interface growth (RIG) mechanism (Weeks and Gilmer, 762 
1979). 763 
 764 
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S3. MPB Solution Method 765 
Whilst the theoretical solution of the MPB equation can only be obtained for some ideal (simple) 766 
cases, numerical solution methods can provide the most convenient and available approach. Lin et al. 767 
(Lin et al., 2016) developed an invariant method of moments to obtain analytical solution of a PB 768 
system, but this method could only be used for solving a one-dimensional homogeneous PB equation 769 
with size independent growth rate. Therefore, many other different numerical solution methods have 770 
been developed, for example, method of characteristics (Gunawan et al., 2004, Sotowa et al., 2000), 771 
moment of classes (David et al., 1995, Puel et al., 2003a), high resolution discretisation schemes 772 
(Gunawan et al., 2004, Ma et al., 2002, Wan et al., 2009), method of lines (Gerstlauer et al., 2001), 773 
finite-element schemes (Gerstlauer et al., 2006), moving grid techniques (Kumar and Ramkrishna, 774 
1997), hierarchical solution strategies based on multilevel discretisation (Pinto et al., 2007, Sun and 775 
Immanuel, 2005), cell-ensemble method (Henson, 2005), Monte Carlo methods (Yu et al., 2015), etc. 776 
In this study, a discretisation method (moment of classes) has been used to solve the MPB equation 777 
(Eq. 1). In this, the three (x1, x2, x3) size domains were discretised into i (i = 1, N1), j (j = 1, N2), k (k 778 
= 1, N3) classes, respectively, where N1, N2, N3 are the total number of classes for the (x1, x2, x3) size 779 
domains and ݔҧଵǡ௜ሺൌ ݔଵǡ௜ െ ݔଵǡ௜ିଵሻǡ ݔҧଶǡ௝ሺൌ ݔଶǡ௝ െ ݔଶǡ௝ିଵሻǡ ݔҧଷǡ௞ሺൌ ݔଷǡ௞ െ ݔଷǡ௞ିଵሻ are the size of the i, j, 780 
k classes for the (x1, x2, x3). Hence a group of N1 u N2 u N3 ordinary differential equations below can 781 
be formulated and solved: 782 ଵ௏೅ሺ௧ሻ  ௗௗ௧  ቂ்ܸ ሺݐሻ ׬ ׬ ׬ Ȱሺݔଵǡ ݔଶǡ ݔଷǡ ݐሻ݀ݔଵ݀ݔଶ݀ݔଷ௫యǡೖ௫యǡೖషభ௫మǡೕ௫మǡೕషభ௫భǡ೔௫భǡ೔షభ ቃ ൅783 ܩଵ൫ݔҧଵǡ௜ǡ ݐ൯ ൤ ௫భǡ೔శభି௫భǡ೔൫௫భǡ೔ି௫భǡ೔షభ൯൫௫భǡ೔శభି௫భǡ೔షభ൯ ׬ ׬ ׬ Ȱሺݔଵǡ ݔଶǡ ݔଷǡ ݐሻ݀ݔଵ݀ݔଶ݀ݔଷ௫యǡೖ௫యǡೖషభ௫మǡೕ௫మǡೕషభ௫భǡ೔௫భǡ೔షభ ൅784 ௫భǡ೔ି௫భǡ೔షభ൫௫భǡ೔శభି௫భǡ೔൯൫௫భǡ೔శభି௫భǡ೔షభ൯ ׬ ׬ ׬ Ȱሺݔଵǡ ݔଶǡ ݔଷǡ ݐሻ݀ݔଵ݀ݔଶ݀ݔଷ௫యǡೖ௫యǡೖషభ௫మǡೕ௫మǡೕషభ௫భǡ೔శభ௫భǡ೔ ൨ + 785 ܩଶ൫ݔҧଶǡ௝ ǡ ݐ൯ ൤ ௫మǡೕశభି௫మǡೕ൫௫మǡೕି௫మǡೕషభ൯൫௫మǡೕశభି௫మǡೕషభ൯ ׬ ׬ ׬ Ȱሺݔଵǡ ݔଶǡ ݔଷǡ ݐሻ݀ݔଵ݀ݔଶ݀ݔଷ௫యǡೖ௫యǡೖషభ௫మǡೕ௫మǡೕషభ௫భǡ೔௫భǡ೔షభ ൅786 ௫మǡೕି௫మǡೕషభ൫௫మǡೕశభି௫మǡೕ൯൫௫మǡೕశభି௫మǡೕషభ൯ ׬ ׬ ׬ Ȱሺݔଵǡ ݔଶǡ ݔଷǡ ݐሻ݀ݔଵ݀ݔଶ݀ݔଷ௫యǡೖ௫యǡೖషభ௫మǡೕశభ௫మǡೕ௫భǡ೔௫భǡ೔షభ ൨ ൅787 ܩଷ൫ݔҧଷǡ௞ǡ ݐ൯ ൤ ௫యǡೖశభି௫యǡೖ൫௫యǡೖି௫యǡೖషభ൯൫௫యǡೖశభି௫యǡೖషభ൯ ׬ ׬ ׬ Ȱሺݔଵǡ ݔଶǡ ݔଷǡ ݐሻ݀ݔଵ݀ݔଶ݀ݔଷ௫యǡೖ௫యǡೖషభ௫మǡೕ௫మǡೕషభ௫భǡ೔௫భǡ೔షభ ൅788 ௫యǡೖି௫యǡೖషభ൫௫యǡೖశభି௫యǡೖ൯൫௫యǡೖశభି௫యǡೖషభ൯ ׬ ׬ ׬ Ȱሺݔଵǡ ݔଶǡ ݔଷǡ ݐሻ݀ݔଵ݀ݔଶ݀ݔଷ௫యǡೖశభ௫యǡೖ௫మǡೕ௫మǡೕషభ௫భǡ೔௫భǡ೔షభ ൨ ൌ  ?  (S.4) 789 
The N1 u N2 u N3 ordinary differential equations obtained, together with initial and boundary 790 
conditions and also the equations for face-specific growth rates, and mass and heat balance in a batch 791 
cooling crystalliser, form a complete set of the PB solution system. Further detail can be found in 792 
literature (David et al., 1995, Ma et al., 2016, Ma and Wang, 2008, Ma et al., 2008, Puel et al., 2003a). 793 
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 794 
S4. Effect of Seeding Temperature 795 
 796 
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 797 
Figure S.1 Evolution of faceted growth rates during crystallisation processes in face direction of (a) 798 
face {101}, (b) face {10-1} and (c) face {011} under different seeding temperature (Tseeds) (or 799 
supersaturations (Sseeds)) (Tseeds = 20.5oC (or Sseeds = 1.5) ± dashed red line; Tseeds = 24.7oC (or Sseeds = 800 
1.4) ± green line; Tseeds = 28.9oC (or Sseeds = 1.3) ± red line; Tseeds = 33.7oC (or Sseeds = 1.2) ± blue line; 801 
Tseeds = 39.0oC (or Sseeds = 1.1) ± light blue line). 802 
 803 
Figure S.2 Evolution of normal distances during crystallisation processes in face direction of (a) face 804 
{101}, (b) face {10-1} and (c) face {011} under different seeding temperature (Tseeds) (or 805 
supersaturations (Sseeds)) (Tseeds = 20.5oC (or Sseeds = 1.5) ± dashed red line; Tseeds = 24.7oC (or Sseeds = 806 
1.4) ± green line; Tseeds = 28.9oC (or Sseeds = 1.3) ± red line; Tseeds = 33.7oC (or Sseeds = 1.2) ± blue line; 807 
Tseeds = 39.0oC (or Sseeds = 1.1) ± light blue line). 808 
 809 
 810 
 811 
(a) (b) (c) 
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S5. Effect of Seed Loading 812 
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 814 
Figure S.3 Evolution of faceted growth rates during crystallisation processes in face direction of (a) 815 
face {101}, (b) face {10-1} and (c) face {011} under different seed loading (Xseeds) (Xseeds = 0.1% ± 816 
dashed red line; Xseeds = 0.5% ± green line; Xseeds = 1.0% ± red line; Xseeds = 2.0% ± purple line; Xseeds 817 
= 5.0% ± blue line).  818 
 819 
Figure S.4 Evolution of normal distances during crystallisation processes in face direction of (a) face 820 
{101}, (b) face {10-1} and (c) face {011} under different seed loading (Xseeds) (Xseeds = 0.1% ± dashed 821 
red line; Xseeds = 0.5% ± green line; Xseeds = 1.0% ± red line; Xseeds = 2.0% ± purple line; Xseeds = 5.0% 822 
± blue line). 823 
 824 
 825 
 826 
 827 
 828 
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S6. Effect of Seed Mean Shape 829 
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 831 
Figure S.5 Evolution of faceted growth rates during crystallisation processes in face direction of (a) 832 
face {101}, (b) face {10-1} and (c) face {011} under different seed mean shape (Mseeds) with standard 833 
deviations of Vx, Vy, Vz = 8 Pm (Mseeds = (22, 27, 6 Pm) ± dashed red line; Mseeds = (22, 27, 40 Pm) ± 834 
green line; Mseeds = (22, 27, 131 Pm) ± red line). 835 
 836 
 837 
Figure S.6 Evolution of normal distances during crystallisation processes in face direction of (a) face 838 
{101}, (b) face {10-1} and (c) face {011} under different seed mean shape (Mseeds) with standard 839 
deviations of Vx, Vy, Vz = 8 Pm (Mseeds = (22, 27, 6 Pm) ± dashed red line; Mseeds = (22, 27, 40 Pm) ± 840 
green line; Mseeds = (22, 27, 131 Pm) ± red line).  841 
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